Evidence map›Paper›PMID 30611204›Full record

Observational studyBMC infectious diseases2019

Clinical characteristics of HIV-1-infected patients with high levels of plasma interferon-γ: a multicenter observational study.

Dai Watanabe, Tomoko Uehira, Sachiko Suzuki, Erina Matsumoto, Takashi Ueji, Kazuyuki Hirota, Rumi Minami, Soichiro Takahama, Kimikazu Hayashi, Morio Sawamura and 2 more

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in BMC infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Dai WatanabeAIDS Medical Center, National Hospital Organization Osaka National Hospital, 2-1-14, Hoenzaka, Chuo-ku, Osaka City, Osaka, 540-0006, Japan. dai@onh.go.jp.ORCID http://orcid.org/0000-0003-3838-0961
Tomoko UehiraAIDS Medical Center, National Hospital Organization Osaka National Hospital, 2-1-14, Hoenzaka, Chuo-ku, Osaka City, Osaka, 540-0006, Japan.
Sachiko SuzukiAIDS Medical Center, National Hospital Organization Osaka National Hospital, 2-1-14, Hoenzaka, Chuo-ku, Osaka City, Osaka, 540-0006, Japan.
Erina MatsumotoAIDS Medical Center, National Hospital Organization Osaka National Hospital, 2-1-14, Hoenzaka, Chuo-ku, Osaka City, Osaka, 540-0006, Japan.
Takashi UejiAIDS Medical Center, National Hospital Organization Osaka National Hospital, 2-1-14, Hoenzaka, Chuo-ku, Osaka City, Osaka, 540-0006, Japan.
Kazuyuki HirotaAIDS Medical Center, National Hospital Organization Osaka National Hospital, 2-1-14, Hoenzaka, Chuo-ku, Osaka City, Osaka, 540-0006, Japan.
Rumi MinamiInternal Medicine, Clinical Research Institute, National Hospital Organization, Kyushu Medical Center, 1-8-1, Jigyohama, Chuo-ku Fukuoka City, Fukuoka, 810-8563, Japan.
Soichiro TakahamaInternal Medicine, Clinical Research Institute, National Hospital Organization, Kyushu Medical Center, 1-8-1, Jigyohama, Chuo-ku Fukuoka City, Fukuoka, 810-8563, Japan.
Kimikazu HayashiDepartment of Obstetrics and Gynecology, National Organization Kanmon Medical Center, 1-1, Chofusotouracho, Shimonoseki City, Yamaguchi, 752-8510, Japan.
Morio SawamuraDepartment of Clinical Research, National Hospital Organization Shibukawa Medical Center, 383, Shiroi, Shibukawa City, Gunma, 377-0280, Japan.
Masahiro YamamotoInternal Medicine, Clinical Research Institute, National Hospital Organization, Kyushu Medical Center, 1-8-1, Jigyohama, Chuo-ku Fukuoka City, Fukuoka, 810-8563, Japan.
Takuma ShirasakaAIDS Medical Center, National Hospital Organization Osaka National Hospital, 2-1-14, Hoenzaka, Chuo-ku, Osaka City, Osaka, 540-0006, Japan.
Osaka National Hospital · JPNational Kyushu Medical Center · JPNational Hospital Organization · JP

Funding

National Hospital Organization (JP) H26-NHO (AIDS)-03
6 · The paper itself

Abstract

backgroundCirculating interferon-γ (IFN-γ) concentration may be sustained at a high level regardless of the initiation of antiretroviral therapy (ART) in some patients with HIV-1 infection. In the present study, we examined the clinical characteristics of HIV-1-infected patients with high levels of plasma IFN-γ.

methodsThe study subjects were patients infected with HIV-1 who were either naïve to ART with CD4

resultsThe high IFN-γ group included 41 patients (21%). Compared to the patients on ART with low IFN-γ levels, those on ART in the high IFN-γ group were more likely to be younger than 50 years of age (P = 0.0051) and less likely to have dyslipidemia (P = 0.0476) or to be on a protease inhibitor (P = 0.0449). There was no significant difference between groups in the median increase of CD4

conclusionWe concluded that HIV-1-infected patients with high levels of circulating IFN-γ did not have a higher rate of comorbidities related to immune activation. However, they exhibited lower CD4

Indexed as

AdultAnti-Retroviral AgentsCD4 Lymphocyte CountCD4-Positive T-LymphocytesDrug Resistance, ViralFemaleHIV-1HIV InfectionsHIV SeropositivityHumansInterferon-gammaInterleukin-6MaleMiddle AgedRNA, ViralAnti-Retroviral AgentsInterferon-gammaInterleukin-6RNA, ViralCD4+ cell count recoveryHIV-1 infectionInterferon-γInterleukin-6

Identifiers

PMID30611204
PMCPMC6321664
OpenAlexW2913753851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.